Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?) These two companies fit the type of transformative growth story Cathie Wood seeks out. Barchart · Sep 15, 2025
3 Cathie Wood Biotech Stocks That Analysts Expect to Double This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling. Barchart · Jun 3, 2024
Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines. International Business Times UK · May 23, 2024
Erasing or replacing errors in a patient's genetic code can treat and cure some genetic diseases Genetic diseases can have devastating consequences for the people who inherit them. In recent years, scientists have found that there are human genetic diseases that might be treatable, and perhaps even curable, through gene editing. Gene editing is the process by which sections of a person’s DNA are altered. Commonly… The Conversation · Apr 19, 2023